Cargando…
Deep learning for in vitro prediction of pharmaceutical formulations
Current pharmaceutical formulation development still strongly relies on the traditional trial-and-error methods of pharmaceutical scientists. This approach is laborious, time-consuming and costly. Recently, deep learning has been widely applied in many challenging domains because of its important ca...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362259/ https://www.ncbi.nlm.nih.gov/pubmed/30766789 http://dx.doi.org/10.1016/j.apsb.2018.09.010 |
_version_ | 1783392878609825792 |
---|---|
author | Yang, Yilong Ye, Zhuyifan Su, Yan Zhao, Qianqian Li, Xiaoshan Ouyang, Defang |
author_facet | Yang, Yilong Ye, Zhuyifan Su, Yan Zhao, Qianqian Li, Xiaoshan Ouyang, Defang |
author_sort | Yang, Yilong |
collection | PubMed |
description | Current pharmaceutical formulation development still strongly relies on the traditional trial-and-error methods of pharmaceutical scientists. This approach is laborious, time-consuming and costly. Recently, deep learning has been widely applied in many challenging domains because of its important capability of automatic feature extraction. The aim of the present research is to apply deep learning methods to predict pharmaceutical formulations. In this paper, two types of dosage forms were chosen as model systems. Evaluation criteria suitable for pharmaceutics were applied to assess the performance of the models. Moreover, an automatic dataset selection algorithm was developed for selecting the representative data as validation and test datasets. Six machine learning methods were compared with deep learning. Results showed that the accuracies of both two deep neural networks were above 80% and higher than other machine learning models; the latter showed good prediction of pharmaceutical formulations. In summary, deep learning employing an automatic data splitting algorithm and the evaluation criteria suitable for pharmaceutical formulation data was developed for the prediction of pharmaceutical formulations for the first time. The cross-disciplinary integration of pharmaceutics and artificial intelligence may shift the paradigm of pharmaceutical research from experience-dependent studies to data-driven methodologies. |
format | Online Article Text |
id | pubmed-6362259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-63622592019-02-14 Deep learning for in vitro prediction of pharmaceutical formulations Yang, Yilong Ye, Zhuyifan Su, Yan Zhao, Qianqian Li, Xiaoshan Ouyang, Defang Acta Pharm Sin B Original article Current pharmaceutical formulation development still strongly relies on the traditional trial-and-error methods of pharmaceutical scientists. This approach is laborious, time-consuming and costly. Recently, deep learning has been widely applied in many challenging domains because of its important capability of automatic feature extraction. The aim of the present research is to apply deep learning methods to predict pharmaceutical formulations. In this paper, two types of dosage forms were chosen as model systems. Evaluation criteria suitable for pharmaceutics were applied to assess the performance of the models. Moreover, an automatic dataset selection algorithm was developed for selecting the representative data as validation and test datasets. Six machine learning methods were compared with deep learning. Results showed that the accuracies of both two deep neural networks were above 80% and higher than other machine learning models; the latter showed good prediction of pharmaceutical formulations. In summary, deep learning employing an automatic data splitting algorithm and the evaluation criteria suitable for pharmaceutical formulation data was developed for the prediction of pharmaceutical formulations for the first time. The cross-disciplinary integration of pharmaceutics and artificial intelligence may shift the paradigm of pharmaceutical research from experience-dependent studies to data-driven methodologies. Elsevier 2019-01 2018-09-28 /pmc/articles/PMC6362259/ /pubmed/30766789 http://dx.doi.org/10.1016/j.apsb.2018.09.010 Text en © 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original article Yang, Yilong Ye, Zhuyifan Su, Yan Zhao, Qianqian Li, Xiaoshan Ouyang, Defang Deep learning for in vitro prediction of pharmaceutical formulations |
title | Deep learning for in vitro prediction of pharmaceutical formulations |
title_full | Deep learning for in vitro prediction of pharmaceutical formulations |
title_fullStr | Deep learning for in vitro prediction of pharmaceutical formulations |
title_full_unstemmed | Deep learning for in vitro prediction of pharmaceutical formulations |
title_short | Deep learning for in vitro prediction of pharmaceutical formulations |
title_sort | deep learning for in vitro prediction of pharmaceutical formulations |
topic | Original article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362259/ https://www.ncbi.nlm.nih.gov/pubmed/30766789 http://dx.doi.org/10.1016/j.apsb.2018.09.010 |
work_keys_str_mv | AT yangyilong deeplearningforinvitropredictionofpharmaceuticalformulations AT yezhuyifan deeplearningforinvitropredictionofpharmaceuticalformulations AT suyan deeplearningforinvitropredictionofpharmaceuticalformulations AT zhaoqianqian deeplearningforinvitropredictionofpharmaceuticalformulations AT lixiaoshan deeplearningforinvitropredictionofpharmaceuticalformulations AT ouyangdefang deeplearningforinvitropredictionofpharmaceuticalformulations |